Instil Bio, Inc.(TIL)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | Laumas Sandeep CFO and CBO | Sale | -30,000 | -100.00%0 | $23.39 | $701,667 | View SEC filing | |
| 2021-03-25 | Vivo Capital Fund IX, L.P. 10% Owner | Purchase | +300,000 | +2.46%12,486,787 | $20.00 | $6,000,000 | View SEC filing | |
| 2021-03-25 | Shah Nimish P Director | Purchase | +300,000 | +4.57%6,865,076 | $20.00 | $6,000,000 | View SEC filing | |
| 2021-03-25 | Nielsen Jack Director | Purchase | +300,000 | +2.46%12,486,787 | $20.00 | $6,000,000 | View SEC filing | |
| 2021-03-25 | McGaughy R Kent Jr Director | Purchase | +450,000 | +5.60%8,478,790 | $20.00 | $9,000,000 | View SEC filing | |
| 2021-03-25 | Curative Ventures V LLC 10% Owner | Purchase | +450,000 | +1.20%37,980,073 | $20.00 | $9,000,000 | View SEC filing | |
| 2021-03-25 | Crouch Bronson CEO and Chairman | Purchase | +450,000 | +1.20%37,980,073 | $20.00 | $9,000,000 | View SEC filing |
1-7 of 7